Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
Rang in aandelen
#4354
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Aandeelprijs
$2.41
Marktkapitalisatie
$3.61B
Verandering (1 dag)
-0.60%
Verandering (1 jaar)
-10.36%
Land
CN
Handel Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Categorie
Healthcare
Winst voor Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Winst in Jun 2026 TTM: $116.37M
Volgens de meest recente financiële verslagen van Zhejiang Huahai Pharmaceutical Co., Ltd. bedraagt de huidige winst van het bedrijf $116.37M. In 2023 behaalde het bedrijf een winst van $155.44M, een daling ten opzichte van de winst van 2022, die $218.75M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Zhejiang Huahai Pharmaceutical Co., Ltd. van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $116.37M | -41.96% |
| 2024 | $200.52M | 29.00% |
| 2023 | $155.44M | -28.94% |
| 2022 | $218.75M | 76.68% |
| 2021 | $123.81M | -33.45% |
| 2020 | $186.04M | 70.26% |
| 2019 | $109.27M | 378.00% |
| 2018 | $22.86M | -80.91% |
| 2017 | $119.77M | 46.64% |
| 2016 | $81.68M | 1.26% |
| 2015 | $80.66M | 59.65% |
| 2014 | $50.52M | -25.67% |
| 2013 | $67.97M | 5.47% |
| 2012 | $64.44M | 48.73% |
| 2011 | $43.33M | 123.78% |
| 2010 | $19.36M | -32.37% |
| 2009 | $28.63M | 16.51% |
| 2008 | $24.57M | -5.07% |
| 2007 | $25.88M | 35.84% |
| 2006 | $19.05M | -12.70% |
| 2005 | $21.83M | 10.70% |
| 2004 | $19.72M | 36.00% |
| 2003 | $14.50M | 63.58% |
| 2002 | $8.86M | 36.52% |
| 2001 | $6.49M | 2.99% |
| 2000 | $6.30M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 1,416.29% |
IN
|
